Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated to proteinaceous toxin or fragment thereof
Patent
1995-09-26
1997-06-03
Scheiner, Toni R.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated to proteinaceous toxin or fragment thereof
4241781, 5303911, 5303917, 530402, 530410, A61K 39395, C07K 1600
Patent
active
056351801
ABSTRACT:
There is disclosed charge-modified conjugates comprising a targeting protein bound to a therapeutic or diagnostic agent. Charge-modifying a conjugate to cause an acidic shift in the isoelectric point results in prolonged serum half-life upon in vivo administration and is useful to accumulate a therapeutic agent at the target site. Conversely, charge-modification to cause a basic shift in the isoelectric point of the conjugate reduces serum half-life upon in vivo use for diagnostic imaging purposes and results in higher target-to-background ratios.
REFERENCES:
patent: 4082507 (1978-04-01), Sawyer
patent: 4545885 (1985-10-01), Paston et al.
patent: 5322678 (1994-06-01), Morgan et al.
Waldmann, T.A., Science, 252:1657-1662, 1991.
Trovet et al, PNAS 79, 1982 pp. 626-629.
Vogt et al, Kidney International, 22, 1982, pp. 27-35.
Mennik et al, J. Immunol. 38 (11) 1987, pp. 4209-4217.
Ulloc.-Ayvirie et al, Human Reproduction 3(4) 1988 (Aug.) pp. 491-501.
Wacbsmotle et al, Res. J. Reticuloendothel, Soc. 24 (3) 1978, pp. 227-241.
Holcenberg et al., J. Biol Chem. 250 (11) 1975, pp. 4165-4107.
Vogt, Arnold, "Interaction of Cationized Antigen with Rat Glomerular Basemen Membrane: In Situ Immune Complex Formation," International Society of Nephrology, 27-35, 1982.
Abrams Paul G.
Morgan, Jr. Alton C.
Sivam Gowsala P.
NeoRx Corporation
Scheiner Toni R.
Ungar Susan
LandOfFree
Alteration of pharmacokinetics of proteins by charge modificatio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alteration of pharmacokinetics of proteins by charge modificatio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alteration of pharmacokinetics of proteins by charge modificatio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-389397